Festive Deal Recombinant Human Layilin/layn Protein (his Tag) + Gift Included [pIZPcnsm]

Festive Deal Recombinant Human Layilin/layn Protein (his Tag) + Gift Included [pIZPcnsm]

Introducing our high-quality Festive Deal Recombinant Human Layilin/layn Protein (his Tag) + Gift Included [pIZPcnsm], a cutting-edge research tool designed for molecular biology and cellular analysis. This protein, expressed in HEK293 cells, is a valuable resource for studying the role of Layilin in various cellular processes. Key features include:

• Expression Host: HEK293 Cells
• Sequence: Met 1-Glu 220
• Accession: NP_849156.1
• Calculated Molecular Weight: 24.2 kDa
• Tag: C-His

Product Properties and Specifications

Our Festive Deal Recombinant Human Layilin/layn Protein (his Tag) + Gift Included [pIZPcnsm] is characterized by high purity, exceeding 97% as determined by reducing SDS-PAGE. It is free from endotoxins, with a level less than 1.0 EU per μg as assessed by the LAL method. This protein is lyophilized from sterile PBS, pH 7.2, and typically contains 5% - 8% trehalose, mannitol, and 0.01% Tween 80 as protectants. Additional specifications include:

• Storage: Stable at -20 to -80℃ for up to 12 months when stored properly.
• Shipping: Provided as lyophilized powder shipped with ice packs for optimal preservation.

Practical Applications and Benefits

This recombinant protein is ideal for researchers investigating the interaction of Layilin with other cellular components, such as talin and hyaluronan (HA). Layilin's role in cell shape, adhesion, motility, and homeostasis makes it a key player in various cellular processes. Moreover, its potential involvement in the invasion and lymphatic metastasis of lung carcinoma adds to its significance in cancer research. By using our Festive Deal Recombinant Human Layilin/layn Protein (his Tag) + Gift Included [pIZPcnsm], researchers can gain deeper insights into the molecular mechanisms behind these processes and contribute to the development of new therapeutic strategies. Target audience includes:

• Cell biologists and molecular biologists
• Cancer researchers
• Pharmaceutical and biotechnology companies